Rationally Designed Polycationic Carriers for Potent Polymeric siRNA-Mediated Gene Silencing

The delivery of small interfering RNA (siRNA) remains a major hurdle for the clinical translation of RNA interference (RNAi) therapeutics. Because of its low valency and rigid nature, siRNA typically requires high excesses of cationic delivery materials to package it stably and deliver it to the cyt...

Full description

Bibliographic Details
Main Authors: Wu, Connie (Author), Li, Jiahe (Author), Wang, Wade (Author), Hammond, Paula T (Author)
Other Authors: Massachusetts Institute of Technology. Department of Chemical Engineering (Contributor), Massachusetts Institute of Technology. Department of Chemistry (Contributor), Koch Institute for Integrative Cancer Research at MIT (Contributor)
Format: Article
Language:English
Published: American Chemical Society, 2019-11-12T18:00:05Z.
Subjects:
Online Access:Get fulltext
LEADER 02154 am a22002293u 4500
001 122901
042 |a dc 
100 1 0 |a Wu, Connie  |e author 
100 1 0 |a Massachusetts Institute of Technology. Department of Chemical Engineering  |e contributor 
100 1 0 |a Massachusetts Institute of Technology. Department of Chemistry  |e contributor 
100 1 0 |a Koch Institute for Integrative Cancer Research at MIT  |e contributor 
700 1 0 |a Li, Jiahe  |e author 
700 1 0 |a Wang, Wade  |e author 
700 1 0 |a Hammond, Paula T  |e author 
245 0 0 |a Rationally Designed Polycationic Carriers for Potent Polymeric siRNA-Mediated Gene Silencing 
260 |b American Chemical Society,   |c 2019-11-12T18:00:05Z. 
856 |z Get fulltext  |u https://hdl.handle.net/1721.1/122901 
520 |a The delivery of small interfering RNA (siRNA) remains a major hurdle for the clinical translation of RNA interference (RNAi) therapeutics. Because of its low valency and rigid nature, siRNA typically requires high excesses of cationic delivery materials to package it stably and deliver it to the cytoplasm of target cells, resulting in high toxicities and inefficient gene silencing in vivo. To address these challenges, we pair a polymeric form of siRNA, p-shRNA, with optimized biodegradable polycations to form stable complexes that induce far more potent gene silencing than with siRNA complexes. Furthermore, we unveil a set of design rules governing p-shRNA delivery, using degradable polycations containing hydrophobic and stabilizing polyethylene glycol domains that enable both stable condensation and efficient release inside cells. We demonstrate the therapeutic potential of this approach by silencing the oncogene STAT3 in a well-established B16F10 mouse melanoma model to significantly prolong survival. By blending nucleic acid engineering and polymer design, our system provides a potentially translatable platform for RNAi-based therapies. Keywords: RNA interference; polycation; gene delivery; siRNA; poly(beta-amino ester) 
520 |a Congressionally Directed Medical Research Programs (U.S.) (Award 13-1-0151, PTH) 
546 |a en 
655 7 |a Article 
773 |t ACS Nano